View Author
scopus: 6701723727

Arns, W.

(Wolfgang Arns)


patient transplantation mpa-auc 0 –12 mycophenolate mofetil study mpa-auc rejection diarrhea transplant group month incidence concentration mycophenolate mycophenolic mofetil mycophenolic acid difference –12 transplant recipients visit acmpag diarrhoea exposure analysis hoffmann-la roche ltd mmf dose signi ficantly signi episode tacrolimu plasma glucuronide +++ day 3 recipient table metabolite department roche signi ficant differences tcl /mmf center fi xed dose transplant patients mpa exposure trial kidney value cyclosporine therapy plasma concentrations pharmacokinetic figure csa /mmf enterohepatic recycling population armstrong vw fdcc study biliary excretion mmf doses event university rejection incidence regimen ficantly ficant signi ficant difference american tcl /mmf regimen research support hoffmann-la range journal gelder wieland e mpa concentrations american journal relationship 1822–1831




2 Most Recent Publications

Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid (Article)
Gelder, T. van Tedesco-Silva, H. Holzer, H. Rostaing, L. Mamelok, R. Fijter, J.W. de Budde, K. Kuypers, D. Arns, W. Paul Soulillou, J. Kanellis, J. Zelvys, A. Ekberg, H.
2010-03-01
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients (Article)
Heller, T. Gelder, T. van MacPhee, I.A.M. Pohanka, E. Engelmayer, J. Brandhorst, G. Oellerich, M. Armstrong, V.W. Budde, K. Fijter, J.W. de Kuypers, D. Arns, W. Schmidt, J. Rostaing, L. Powis, S.H. Claesson, K.
2007-07-01